NCT07580898 Safety of MOON101 for the Treatment of Peanut Allergy Status NOT_YET_RECRUITING Phase PHASE1
NCT07439406 Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy Status NOT_YET_RECRUITING Phase PHASE2
NCT07349212 UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies Status RECRUITING Phase PHASE1/PHASE2
NCT07117669 Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants Status RECRUITING Phase PHASE1/PHASE2
NCT07015996 Efficacy of Tezepelumab in Peanut Oral Immunotherapy Status NOT_YET_RECRUITING Phase PHASE2
NCT07003919 Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) Status RECRUITING Phase PHASE3
NCT06331728 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001 Status COMPLETED Phase PHASE1
NCT06297083 Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy Status WITHDRAWN Phase PHASE2
NCT06256146 Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety Status RECRUITING Phase NA
NCT05695261 Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients Status RECRUITING Phase PHASE2
NCT05667610 Immune-supportive Diet and Gut Permeability in Allergic Children Status RECRUITING Phase NA
NCT05662800 Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food Allergy Status UNKNOWN Phase N/A
NCT05621317 A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05503446 Using Commonly Available Food Products To Treat Food Allergy Status ACTIVE_NOT_RECRUITING Phase NA
NCT05476497 Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05440643 Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy Status COMPLETED Phase PHASE1/PHASE2
NCT05424731 Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children Status AVAILABLE Phase N/A
NCT05165329 A Randomized, Controlled Trial of Probiotic and Peanut Oral Immunotherapy (PPOIT) in Inducing Tolerance in Hong Kong Children With Peanut Allergy Compared With Oral Immunotherapy (OIT) Alone and With Placebo Status ACTIVE_NOT_RECRUITING Phase NA
NCT05163574 Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy Status UNKNOWN Phase NA